No Data
Summit Therapeutics Shares Are Trading Lower. The Company's Partner Akeso Received FDA Approval for Its PD-1 Monoclonal Antibody, Penpulimab-kcqx, in Combination With Cisplatin or Carboplatin and Gemcitabine. The FDA Also Approved Penpulimab-kcqx as a...
'Akeso Wins Chinese Approval For Cancer Drug Positioned To Rival Merck's Keytruda; Company Discloses Early Data Hinting At A Survival Benefit' - STAT News
Hong Kong Stock Morning Report｜Trump is considering a tiered tariff plan for China. Aluminum Corporation Of China reported nearly 60% year-on-year increase in Net income for the first quarter.
① Trump is considering a tiered tariff plan for China. ② Canadian Prime Minister Carney: There is no rush to reach an agreement with Trump; we have enough leverage in the negotiations. ③ Seven departments: Launching a pilot application for 'AI Empowering the Entire Industry Chain of Medicine.' ④ The Commercial Space Innovation Consortium was established yesterday, and relevant industry standards will be accelerated for formulation.
Summit Extends Gains as Cancer Drug Outperforms BeiGene's Tevimbra
Hong Kong stock morning report | John Lee Ka-chiu engaged in in-depth exchanges with representatives of the "Hangzhou Six Little Dragons" companies. Trump is considering exempting Auto Manufacturers from some tariffs.
① John Lee Ka-chiu had in-depth discussions with representatives from the 'Six Little Dragons of Hangzhou.' ② The Inner Mongolia Ministry of Industry and Information Technology reported that the computing power scale of Inner Mongolia has reached around 0.12 million P, ranking first in the country. ③ USA President Trump is considering exempting Auto Manufacturers from certain tariffs. ④ NIO's Li Bin predicts that China's share of the Global auto industry will exceed 40%.
Zai Lab To Present Data From Phase 1 Trial Of DLL3-Targeted Antibody-Drug Conjugate ZL-1310 At 2025 ASCO Annual Meeting
